Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ) Social Stream
Jazz Pharmaceuticals plc (JAZZ) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering JAZZ.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 15 | $250 | $172 | $204.937 | $155.67 | 31.65% |
| 2021-11-11 | 15 | $250 | $172 | $204.312 | $155.67 | 31.25% |
| 2021-11-16 | 15 | $250 | $172 | $204.125 | $155.67 | 31.13% |
| 2021-12-17 | 14 | $250 | $172 | $203.812 | $155.67 | 30.93% |
| 2021-12-20 | 14 | $250 | $172 | $201.937 | $155.67 | 29.72% |
| 2022-01-06 | 14 | $250 | $172 | $202.312 | $155.67 | 29.96% |
| 2022-01-13 | 14 | $250 | $172 | $202.812 | $155.67 | 30.28% |
| 2022-01-23 | 14 | $250 | $172 | $204.562 | $155.67 | 31.41% |
| 2022-02-11 | 12 | $250 | $172 | $204.437 | $155.67 | 31.33% |
| 2022-02-25 | 11 | $250 | $172 | $204.437 | $155.67 | 31.33% |
| 2022-03-02 | 12 | $250 | $172 | $202.866 | $155.67 | 30.32% |
| 2022-03-04 | 14 | $250 | $172 | $202.266 | $155.67 | 29.93% |
| 2022-03-28 | 14 | $250 | $174 | $203.466 | $155.67 | 30.7% |
The Trend in the Analyst Price Target
Over the past 138 days, JAZZ's average price target has gone down $1.47.
Over the past 51 weeks, JAZZ's average upside potential has been 36.71%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-05-08 | 7 | 236 | 176 | 204.350 | 174.59 | 17.05% |
| 2021-08-14 | 18 | 250 | 176 | 209.820 | 142.16 | 47.59% |
| 2021-11-14 | 15 | 250 | 172 | 204.125 | 139.53 | 46.29% |
| 2022-01-23 | 13 | 250 | 172 | 204.562 | 136.76 | 49.58% |
| 2022-02-11 | 12 | 250 | 172 | 204.437 | 141.95 | 44.02% |
JAZZ Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.21 | 12 | 1 | 1 | 0 | 0 | 14 |
The Trend in the Broker Recommendations
Over the past 120 days, JAZZ's average broker recommendation rating worsened by 0.01.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for JAZZ as an investment opportunity.
- In terms of how Jazz Pharmaceuticals plc fares relative to all US stocks, note that its average analyst price target is higher than 1601.36% of that group.
- JAZZ has a higher number of analysts covering the stock than 1611.78% of Pharmaceutical Products stocks.
- In the context of Pharmaceutical Products stocks, Jazz Pharmaceuticals plc's upside potential (average analyst target price relative to current price) is higher than 255.3% of them.
- JAZZ has a lower variance in analysts' estimates than -465.15% of Pharmaceutical Products stocks.
Stocks similar to Jazz Pharmaceuticals plc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are IONS, HZNP, and GSK.
Make investment decisions regarding JAZZ using the data that counts. Try POWR Ratings for free.